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Heightened sensitivity to painful stimulation commonly spreads from the affected limb
to the ipsilateral forehead in patients with complex regional pain syndrome (CRPS). In
addition, acoustic startle evokes greater auditory discomfort and increases in limb pain
when presented on the affected than unaffected side. In contrast, limb pain ordinarily
evokes analgesia in the ipsilateral forehead of healthy participants, and acoustic startle
suppresses limb pain. Together, these findings suggest that hemilateral and generalized
pain control mechanisms are disrupted in CRPS, and that multisensory integrative
processes are compromised. Failure to inhibit nociceptive input from the CRPS-affected
limb could sensitize spinal and supraspinal neurons that receive convergent nociceptive
and auditory information from hemilateral body sites. Somatosensory, auditory, and
emotional inputs may then aggravate pain by feeding into this sensitized nociceptive
network. In particular, a disturbance in hemilateral pain processing that involves the locus
coeruleus could exacerbate the symptoms of CRPS in some patients.
Keywords: complex regional pain syndrome, hemilateral pain modulation, locus coeruleus, startle, psychological
distress
INTRODUCTION
Complex regional pain syndrome (CRPS) usually begins after
a fracture, contusion or sprain, but can develop after a
minor injury that would normally heal quickly. Patients typ-
ically describe a burning sensation that is aggravated by
movement, the limb being touched, and ambient tempera-
ture changes. The pain and sensory disturbances are often so
severe that they lead to profound disability (Marinus et al.,
2011).
In the first detailed description of this syndrome, Mitchell
(1872) noted that arousal stimuli and emotional distress greatly
intensified pain. We recently confirmed this in controlled
studies that involved a standard auditory startle stimulus.
Patients reported that startle stimuli presented on the CRPS-
affected side sounded louder and provoked greater increases
in limb pain than contralateral startle stimuli (Knudsen et al.,
2011). In contrast, heat-pain decreased momentarily in healthy
participants when they were startled (Drummond et al.,
2001).
We also found that sensitivity to painful mechanical pressure
generally extended from the CRPS-affected limb to the ipsilat-
eral forehead (Drummond and Finch, 2006; Finch et al., 2009),
whereas pain referral to the ipsilateral forehead was uncommon
in other forms of chronic unilateral pain (Knudsen et al., 2011).
Since the locus coeruleus responds to nociceptive and alerting
stimuli (Aston-Jones et al., 1991; Jones, 1991; Van Bockstaele
et al., 2001; Valentino and Van Bockstaele, 2008), and is impli-
cated in hemilateral pain modulation (Tsuruoka et al., 2004),
these observations suggest an involvement of the locus coeruleus
in CRPS.
BIDIRECTIONAL INFLUENCES OF SPINAL NORADRENERGIC
ACTIVITY ON PAIN
In emergencies, alarm signals emanating from cortical fear
networks inhibit pain messages as they enter the spinal cord,
akin to closing a “pain gate.” This inhibitory response, known
as “stress-induced analgesia”, is mediated, in part, by spinal
release of noradrenaline (Millan, 2002). Specifically, the central
noradrenergic system (which alerts the brain to the presence
of threats and rewards) activates α2-adrenoceptors in the dor-
sal horn. In turn, this inhibits the release of excitatory neuro-
transmitters from primary nociceptive afferents and blocks pain.
The effectiveness of this anti-nociceptive mechanism sometimes
strengthens following peripheral nerve injury (Ma and Eisenach,
2003; Hayashida et al., 2012). However, under certain conditions,
this spinal anti-nociceptive influence may be compromised after
peripheral nerve injury (Rahman et al., 2008), thereby contribut-
ing to pain.
In addition to inhibitory influences mediated by
α2-adrenoceptors, noradrenaline can activate an excitatory
subclass of adrenergic receptors on primary nociceptive afferents
(the α1-adrenoceptors) (Millan, 1999). Not only does this
intensify pain and hyperalgesia (heightened sensitivity to painful
stimulation) but it also evokes axon reflexes (a fundamental
component of neurogenic inflammation) (Ren et al., 2005;
Drummond, 2009, 2011). Consequently, during acute inflamma-
tion or after nerve injury, noradrenergic facilitation of pain and
inflammation may replace inhibitory noradrenergic effects (Ali
et al., 1999; Dogrul et al., 2006; Donello et al., 2011).
Likewise, noradrenaline may sometimes facilitate central
nociceptive activity (Millan, 2002). For example, in a model
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of inflammatory pain, excitation of α1-adrenoceptors in the
dorsal horn of rats opposed an anti-nociceptive effect medi-
ated by α2-adrenoceptors (Jeong and Holden, 2009). This study
involved stimulation of the lateral hypothalamus with microin-
jection of carbachol, thereby activating adrenergic brainstem
neurons. Under these conditions, inthrathecal injection of the
α1-adrenoceptor antagonist WB4101 increased the foot with-
drawal latency to noxious heating of the inflamed ankle, indi-
cating that spinal α1-adrenoceptors exerted a pro-nociceptive
effect. Similar effects were obtained when brainstem adrenergic
neurons were activated indirectly with pontine microinjection
of morphine (Holden et al., 1999) or the GABAA antagonist
bicuculline (Nuseir and Proudfit, 2000). Activation of brain-
stem α1-adrenoceptors may also suppress pain-inhibitory pro-
cesses, thereby facilitating pain. For example, microinjection of
the α1-adrenoceptor agonist phenylephrine close to the nucleus
raphe magnus suppressed diffuse noxious inhibitory controls in
rats (Makino et al., 2010), consistent with a disruptive role of
α1-adrenoceptors on this pain modulation process.
Additional convergent evidence suggests that brainstem adren-
ergic nuclei are involved in pain-facilitation. For example, fol-
lowing intraplantar formalin injection, locus coeruleus-lesioned
rats spent less time licking or lifting the inflamed hindpaw dur-
ing a hotplate test than control rats (Martin et al., 1999; Taylor
et al., 2000). In a related study, signs of neural activity increased
in the locus coeruleus following spared sural nerve injury, and the
increase correlated with the intensity of tactile allodynia (pain to
a normally innocuous stimulus) (Brightwell and Taylor, 2009).
Importantly, targeted destruction of noradrenergic neurons in
the locus coeruleus by intra-cerebro-ventricular injection of anti-
dopamine-β-hydroxylase-saporin (DβH-saporin) prevented the
development of allodynia and hyperalgesia, as did microinjec-
tion of local anesthetic agent directly into the locus coeruleus.
Similarly, following spared sural nerve injury, microinjection
of phenylephrine into the brainstem dorsal reticular nucleus
induced hyperalgesia and allodynia; conversely, a reduction in
synthesis of noradrenaline in neurons that projected to this
nucleus attenuated signs of pain (Martins et al., 2010). In con-
trast to these reports, spinal depletion of noradrenergic neu-
rons after inthrathecal administration of DβH-saporin enhanced
signs of mechanical hyperalgesia associated with spinal nerve
ligation (Jasmin et al., 2003; Hayashida et al., 2012). Together,
these findings suggest that complete destruction of spinal nora-
drenergic pathways (with partial destruction of brainstem nora-
drenergic nuclei) augments pain (Jasmin et al., 2003; Hayashida
et al., 2012), whereas complete destruction of the locus coeruleus
(but sparing most noradrenergic neurons in the A5 and A7
brainstem nuclei) inhibits pain (Brightwell and Taylor, 2009).
Thus, after peripheral nerve injury, a spinal noradrenergic anti-
nociceptive mechanism that projects from the locus coeruleus
could transform into a pro-nociceptive mechanism, possibly
involving ascending noradrenergic projections in addition to
descending coeruleospinal pathways.
In an important study byHodge et al. (1983), the effect of locus
coeruleus stimulation on the firing rate of cells in lamina 4–5 of
the dorsal horn to noxious skin stimulation was studied after dor-
sal root rhizotomy. On the side contralateral to the rhizotomy,
locus coeruleus stimulation inhibited neural responses to nox-
ious skin stimulation. However, on the lesioned side, locus
coeruleus stimulation sometimes facilitated responses in dorsal
horn neurons, consistent with the transformation of a normal
inhibitory coeruleospinal influence into a facilitatory effect. In
addition to spinal nociceptive projections, a separate popula-
tion of noradrenergic neurons in the locus coeruleus supplies the
somatosensory thalamus (Voisin et al., 2005) where they exert
excitatory and inhibitory effects on nociceptive traffic via α1- and
α2-adrenoceptors, respectively (Zhang et al., 1998). Hence,
under certain conditions, activation of the central noradrenergic
system might facilitate nociceptive neurotransmission, thereby
sensitizing nociceptive neurons at multiple ascending levels.
HEMILATERAL PAIN MODULATION IN AN ANIMAL MODEL
OF ACUTE INFLAMMATORY PAIN
In rats, coeruleospinal pain modulation appears to be active in
the dorsal horn ipsilateral, but not contralateral, to the site of
paw inflammation (Tsuruoka et al., 1999, 2003, 2004). Moreover,
the inhibitory influence extends beyond the involved segment to
distant ipsilateral segments. For example, 4 h after carrageenan-
induced hindpaw inflammation, heat hyperalgesia was detected
not only in the inflamed hindpaw but also in the ipsilateral non-
inflamed forepaw (Tsuruoka et al., 2004). The hyperalgesia inten-
sified both in the inflamed hindpaw and the ipsilateral forepaw
of animals with bilateral lesions of the locus coeruleus, but did
not develop in the contralateral hind- or forepaw. When micro-
dialysis was used to measure the concentration of noradrenaline
in the ipsilateral dorsal horn, noradrenaline increased within 1 h
of the carrageenan injection (Tsuruoka et al., 1999). Importantly,
however, levels did not change in the dorsal horn contralateral to
inflammation, and remained stable during inflammation in the
ipsilateral dorsal horn of rats with bilateral lesions of the locus
coeruleus. The effect of a unilateral or bilateral lesion of the locus
coeruleus-subcoeruleus on paw withdrawal latencies to noxious
heat was investigated by Maeda et al. (2009). Four hours after
carrageenan injection into the hindpaw, paw withdrawal laten-
cies were shorter in animals with bilateral lesions than in animals
with unilateral lesions and in sham-operated controls, consistent
with an inhibitory influence emanating from the locus coeruleus.
However, hyperalgesia was equivalent in sham-operated controls
and in animals with a unilateral lesion on either side. Together,
these findings suggest that carrageenan inflammation activates
adrenergic neurons that project from both sides of the locus
coeruleus to the ipsilateral dorsal horn, and that activity on only
one side is sufficient to inhibit pain.
In sum, pain may evoke the ipsilateral release of noradrenaline
in themedullary and dorsal horn. Speculatively, arousal and stress
associated with pain could further increase this release. Under
normal conditions, a hemilateral inhibitory influence of nora-
drenaline, mediated by α2-adrenoceptors, then closes the spinal
“pain gate” (Figure 1).
HEMILATERAL PAIN MODULATION IN HEALTHY HUMANS
We recently identified the counterpart of this hemilateral anti-
nociceptive response in healthy humans. In our first study, sen-
sitivity to sharp and blunt pressure was measured on each side of
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FIGURE 1 | Model of hemilateral inhibitory pain modulation (in bold). The dashed lines represent failure to engage hemilateral facilitatory pain transmission
and associated emotional distress.
the forehead before and after immersion of one hand in painfully
cold water (Knudsen and Drummond, 2009). Immersion of the
hand in mildly painful (10◦C) water was ineffective, whereas sen-
sitivity to blunt pressure decreased on both sides of the forehead
following a single immersion of the hand in water at 2◦C or
repeated immersions at 4◦C (intensely painful). Importantly, this
decrease was greater on the ipsilateral than contralateral side of
the forehead, consistent with hemilateral pain modulation.
These findings were at odds with animal studies that demon-
strated hyperalgesia in the ipsilateral forepaw after hindpaw injec-
tion of the inflammatory agent carrageenan (Tsuruoka et al.,
2004). Therefore, in a second experiment, sensitivity to mechan-
ical stimulation was assessed on each side of the forehead during
two days of treatment of the forearm with topical capsaicin,
a substance that induces neurogenic inflammation (Knudsen
and Drummond, 2011). Again, the decrease in sensitivity to
blunt pressure was greater on the ipsilateral than contralat-
eral side of the forehead when the forearm site was heated.
Thus, limb pain, possibly compounded by emotional distress,
appears to provoke analgesia in the ipsilateral forehead of healthy
humans.
UP-REGULATIONOFα1-ADRENOCEPTORSON NOCICEPTIVE
AFFERENT FIBERS AFTER NERVE INJURY
It has long been suspected that α1-adrenoceptors are
expressed on primary nociceptive afferents. Messenger RNA
for α1-adrenoceptors is present in the dorsal root ganglia (DRG)
of rats (Nicholson et al., 2005), and noradrenaline and the
α1-adrenoceptor agonist phenylephrine increase the excitability
of cultured DRG neurons (Kasai and Mizumura, 2001; Pluteanu
et al., 2002). We recently used immunohistochemistry to confirm
the expression of α1-adrenoceptors within sub-populations
of nociceptive neurons in the DRG and skin of rats (Dawson
et al., 2011). These neurons expressed α1-adrenoceptors, thus
providing a histochemical substrate for direct excitation by
adrenergic agonists (Gibbs et al., 2008).
Injury to adrenergic nerve fibers within the central nervous
system triggers signs of denervation supersensitivity, mediated
by an increased density of post-synaptic adrenergic receptors
(Roudet et al., 1993; Giroux et al., 1999). Likewise, within the
peripheral nervous system, nerve injury provokes signs of an up-
regulated expression of adrenergic receptors. For example, the
proportion of DRG neurons that responded to noradrenaline
increased markedly in rats after chronic nerve injury induced by
loose or tight ligation of the sciatic nerve (Petersen et al., 1996),
and systemic injection of the α1-adrenoceptor antagonist pra-
zosin inhibited nociceptive fiber discharge in other neuropathic
painmodels (Nam et al., 2000; Hord et al., 2001; Kim et al., 2005).
Moreover, messenger RNA for α1B-adrenoceptors increased in
the DRG following peripheral nerve section or ligation of spinal
nerves supplying those ganglia (Xie et al., 2001; Maruo et al.,
2006).
Similar effects have been observed in additional mod-
els of peripheral neuropathy. For example, stimulation of
α1-adrenoceptors aggravated allodynia in an animal model of
painful diabetic neuropathy;moreover,messenger RNA and bind-
ing sites for α1-adrenoceptors increased in the DRG (Lee et al.,
2000). In addition, cells in rat DRG infected with the varicella-
zoster virus gained an unusual sensitivity to the α1-adrenoceptor
agonist phenylephrine (Schmidt et al., 2003). Together, these
findings suggest that heightened α1-adrenoceptor activity may
aggravate symptoms in various neuropathic pain syndromes.
HYPOTHESIS: UP-REGULATEDα1-ADRENOCEPTORS
DISRUPT HEMILATERAL PAIN MODULATION IN CRPS
During the early stages of CRPS, affected skin typically is flushed,
hot and dry, implying diminished sympathetic vasoconstric-
tor and sudomotor activity; but later on the skin becomes
cold, clammy and cyanotic, suggestive of excessive sympathetic
neural discharge (Birklein, 2005). Despite this clinical pic-
ture, there is no direct evidence of an increase in sympathetic
outflow in chronically-affected limbs (Casale and Elam, 1992;
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Dotson, 1993), and no increase in reflex vasoconstrictor responses
(Wasner, 2010). In fact, levels of venous noradrenaline and its
metabolites are lower in the affected than unaffected limbs of
patients with CRPS (Drummond et al., 1991; Harden et al.,
1994). Nevertheless, directly applied adrenergic agents provoke
augmented vasoconstrictor responses in the CRPS-affected limb
(Arnold et al., 1993) and in animal models of CRPS (Kurvers
et al., 1998; Xanthos et al., 2008). One explanation for this
paradox is that an underlying sympathetic deficit, possibly trig-
gered by the inciting trauma, initiates compensatory increases in
the sensitivity or expression of adrenergic receptors in affected
tissues.
In our working model of pain mediation in CRPS
(Drummond, 2010), we propose that the excitatory actions
of α1-adrenoceptors overwhelm the inhibitory actions of
α2-adrenoceptors both within peripheral and central nociceptive
pathways (Figure 2). Specifically, we hypothesize that the noci-
ceptive effects of noradrenaline, mediated by α1-adrenoceptors,
effectively mask opposing inhibitory influences of noradrenaline,
mediated by α2-adrenoceptors.
The excitatory effects of noradrenaline may trigger the hemi-
lateral spread of sensitization from activated second-order noci-
ceptive neurons in the dorsal horn to higher-order convergent
neurons in the brainstem, thalamus, and cerebral cortex. In turn,
amplified pain messages could switch on pain modulation pro-
cesses that attempt to close the pain gate. Consequently, activation
of the central noradrenergic system during heightened states of
arousal, psychological stress—and possibly even pain itself—may
paradoxically intensify pain. If so, a spiral of noradrenaline release
and pain escalation may prevent normal pain resolution. This
new concept could be important not only for clarifying mecha-
nisms of symptom expression in neuropathic pain disorders such
as CRPS, but also for identifying new treatment targets.
HYPOTHESIZED MECHANISM OF SYMPTOM EXPRESSION
IN CRPS
A pro-nociceptive influence emanating from the locus coeruleus
would explain why ipsilateral startle stimuli intensify the pain of
CRPS (Knudsen et al., 2011). Alternatively, startle stimuli might
trigger peripheral release of noradrenaline which then excites a
nociceptive focus in the painful limb (Drummond and Finch,
2004). However, if this was the only mechanism, contralateral
startle stimuli ought to have been as effective as ipsilateral star-
tle stimuli in provoking pain (Knudsen et al., 2011). Moreover,
we found that the pro-nociceptive influence of startle persisted
in a subgroup of patients despite effective sympathetic blockade
(Drummond and Finch, 2004). Thus, startle stimuli may also
amplify the pain of CRPS by acting on disinhibited or sensitized
central nociceptive circuits.
Hyperacusis (heightened sensitivity and discomfort to sound)
is common in severely-affected patients with CRPS (de Klaver
et al., 2007), particularly when acoustic stimuli are presented
to the ipsilateral ear (Knudsen et al., 2011). Adrenergic brain-
stem nuclei provide both inhibitory and excitatory influences to
the cochlear nucleus (Chikamori et al., 1980; Ebert, 1996), the
first link in the neural pathway that underlies the acoustic startle
response (Yeomans et al., 2002). Adrenergic and nociceptive sig-
nals also converge in the thalamus (Zhang et al., 1997) and limbic
system (Ferry et al., 1997). Hence, a facilitatory adrenergic influ-
ence evoked by startle stimuli could contribute to hyperacusis in
CRPS at multiple sites within the central nervous system.
Limb pain usually suppresses less intense pain elsewhere in
the body, including the forehead (Knudsen and Drummond,
2009, 2011). Nevertheless, we found that sensitivity to pressure-
pain increased in the forehead of CRPS patients during intensely
painful stimulation of the affected limb, suggesting that inhibitory
pain modulation processes had failed (Knudsen et al., 2011).
FIGURE 2 | A vicious cycle involving up-regulated α1-adrenoceptors on primary nociceptive afferents may overwhelm inhibitory spinal pain
modulation in CRPS and certain other chronic neuropathic pain syndromes, resulting in pain escalation and emotional distress.
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This failure is consistent with a switch from anti-nociceptive to
pro-nociceptive influences emanating from the locus coeruleus.
A shift toward pain facilitation in the rostral projections of the
hemilateral pain modulation system might also explain the pres-
ence of hyperalgesia in the ipsilateral forehead of CRPS patients
(Drummond and Finch, 2006; Finch et al., 2009; Knudsen
et al., 2011). During attacks of migraine, allodynia extends
within hours from the site of headache to the ipsilateral limbs
(Burstein et al., 2000a,b), implying the spread of sensitization
from primary nociceptive afferents and second-order neurons
in the trigeminal dorsal horn to higher-order hemilateral con-
vergent neurons. Similarly, sensitization might spread through
pain circuits in CRPS, ultimately distorting sensory process-
ing hemilaterally. Failure of hemilateral inhibitory pain control
could accelerate this process (Figure 2). A similar explanation
might account for nociceptive effects evoked by wearing pris-
matic goggles that deviate vision toward the affected side in CRPS
(Sumitani et al., 2007), and by ambiguous visual stimuli (Cohen
et al., 2012).
Some observations do not fit with the idea of a central
adrenergic influence on pain in CRPS. For example, anecdotal
reports suggest that tricyclic antidepressants help some patients
(Rowbotham, 2006). Further trials are required to determine
whether benefits can be identified in randomized controlled stud-
ies and, if so, whether this applies across the board or just
to a subgroup of patients without central adrenergic media-
tion of pain. Whether benefits are due to decreased reuptake of
noradrenaline in spinal pathways or some other mechanism (e.g.,
sodium channel blockade or down-regulation of spinal adreno-
ceptors or associated G-protein coupling) is also unknown.
FUTURE PERSPECTIVES
Similar to most other chronic pain syndromes (Saariaho et al.,
2011), a history of negative life events may increase vulnerability
to CRPS (Geertzen et al., 1998). Although many processes could
contribute to fear-pain conditioning (Bruijnzeel et al., 1999),
from the current perspective it would be interesting to explore
the involvement of brainstem adrenergic nuclei. For example, if
the anti-nociceptive effects of central noradrenaline release trans-
form into pro-nociceptive effects, activity in hyper-excitable fear
and painmodulation circuits might lock in a cycle of chronic pain
and distress.
In terms of treatment, benefits of α1-adrenoceptor block-
ade for CRPS have been described in case reports (Abram and
Lightfoot, 1981; Stevens et al., 1993) but have yet to be evalu-
ated in randomized-controlled trials. Nevertheless, involvement
of α1-adrenoceptors at spinal or supraspinal levels is an intrigu-
ing possibility that may have potential treatment implications for
certain patients with CRPS or other chronic neuropathic pain
syndromes.
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